Efficacy and safety of rFVIIIFc prophylaxis in pediatric, adolescent, and adult subjects with severe hemophilia A over 3–4 years: the ASPIRE study - Nolan, B; Konkle, B A; Mahlangu, J (Res Pract Thromb Haemost PB 1774, 2017)